interesting, that the comments have been that the Isradipine study/results would be icing on the cake. But seems the cake (sales/revenue) as a result of approved product launches is no where to be seen.
Reminiscent of the days of BREAD CRUMBS, when Sequest was the sole product in the cross hairs for Elites ultimate success. When that bombed, suddenly BREAD CRUMBS mysteriously flip/flopped into the new lucrative focus of the incompetent CEO.
Now its the 3rd lifeline for Elite - Isradipine. Something they wont prosper from in any meaningful way, if at all. But as a hedge from further embarrassment, Isradipine is referred to as the "icing on the cake" but as pointed out, wheres the cake? lol
I had same thought last night but already did my one post of the day. Is it possible Lannett/Elite silently launched Adderall without a PR? I would think the prescribers on this board would have posted so if it were true.
You are absolutely right and if the non launching is any indication of what will happen with isradipin, if approved, I would say that it is nothing to get too excited about. It will no doubt just be another disappointment.